Dynavax Technologies Corporation Made Headway
Tue, May 19, 2020 at 05:40 PM
Dynavax Technologies Corporation (DVAX:NASDAQ) rocketted at $6.51, representing a gain of 34%. On Mon 18 May 20, DVAX:NASDAQ hit a New 2-Week High of $4.86. The stock appeared on our News Catalysts scanner on Tue 19 May 20 at 04:46 PM in the 'BIOTECH' category. From Mon 04 May 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed 06 May 20 at $5.44 with a volume of 7M+, and its share price has been moving sideways in recent weeks.
About Dynavax Technologies Corporation (DVAX:NASDAQ)
Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor ("TLR") stimulation.
Top 10 Gainers:
- Nano Dimension Ltd. (NNDM:NASDAQ), 341.67%
- ShiftPixy, Inc. (PIXY:NASDAQ), 51.64%
- AeroCentury Corp. (ACY:NYSEMKT), 37.97%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 37.86%
- Dynavax Technologies Corporation (DVAX:NASDAQ), 33.95%
- ArTara Therapeutics, Inc. (TARA:NASDAQ), 32.75%
- I-Mab (IMAB:NASDAQ), 31.56%
- Acer Therapeutics Inc. (ACER:NASDAQ), 29.43%
- Iterum Therapeutics plc (ITRM:NASDAQ), 26.96%
- Heat Biologics, Inc. (HTBX:NASDAQ), 26.87%